Immuneering Corp
NASDAQ:IMRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
CDTi Advanced Materials Inc
OTC:CDTI
|
US |
|
C
|
China Energy Engineering Corp Ltd
SSE:601868
|
CN |
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Huishang Bank Corp Ltd
HKEX:3698
|
CN |
|
Sinopec Engineering Group Co Ltd
HKEX:2386
|
CN |
|
S
|
Safety Godown Co Ltd
HKEX:237
|
HK |
|
Micro-Mechanics Holdings Ltd
SGX:5DD
|
SG |
|
T
|
Torm PLC
CSE:TRMD A
|
UK |
|
Star Mica Holdings Co Ltd
TSE:2975
|
JP |
|
Indal Aluminium Industry Tbk PT
IDX:INAI
|
ID |
|
Adairs Ltd
ASX:ADH
|
AU |
|
S
|
Shanghai Fudan Forward S&T Co Ltd
SSE:600624
|
CN |
|
C
|
China Tianrui Group Cement Co Ltd
F:T18
|
CN |
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
IN |
|
Big Rock Brewery Inc
TSX:BR
|
CA |
|
Duran Dogan Basim Ve Ambalaj Sanayi AS
IST:DURDO.E
|
TR |
|
Vonex Ltd
ASX:VN8
|
AU |
|
Nigbas Nigde Beton Sanayii ve Ticaret AS
IST:NIBAS.E
|
TR |
|
L
|
Lypsa Gems & Jewellery Ltd
NSE:LYPSAGEMS
|
IN |
|
T
|
Triton Development SA
WSE:TRI
|
PL |
|
Aeon Metals Ltd
ASX:AML
|
AU |
|
CMTSU Liquidation Inc
OTC:CBRI
|
US |
|
MHM Automation Ltd
NZX:MHM
|
NZ |
Multiples-Based Value
The Multiples-Based Value for Immuneering Corp (IMRX) under the Base Case is hidden USD. Compared with the current market price of 4.88 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
IMRX Competitors Multiples
Immuneering Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
I
|
Immuneering Corp
NASDAQ:IMRX
|
315.5m USD | 0 | -5.6 | -2.4 | -2.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.2 | 35 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |